|
India’s rising exports to Brazil signal trust in its pharma capabilities: Pharma trade experts
|
|
Shardul Nautiyal, Mumbai
July 03 , 2025
|
|
|
India’s rising exports to Brazil signal trust in its pharmaceutical capabilities, while imports from Brazil into India demonstrate the balanced and mutually beneficial nature of this trade partnership, informed pharma trade experts.
“Brazil being the largest country in the Latin American and Caribbean (LAC) region registered a positive growth of 5.95% in exports during April 2025. LAC had a 1.05% share in imports with USD 91.34 million. India’s total imports in 2024-25 amounted to USD 8,188.26 million, with April 2025 imports at USD 748.56 million,” according to official data.
Major collaborations between Brazil and India were also a part of the ongoing discussions with Kenneth Felix Haczynski da Nóbrega, Ambassador of Brazil to India particularly in the areas of contract manufacturing organizations (CMOs) and the co-development of innovative molecules. This is further to the discussions around strengthening existing agreements and fostering new business collaborations.
Ambassador of Brazil to India emphasized the strengthening of Brazil-India relations, particularly in sectors such as healthcare and pharmaceuticals. The Ambassador has consistently highlighted the deepening bilateral ties between the two nations, focusing on shared values, mutual trust, and collaborative efforts in various domains.
Echoing similar sentiments, Namit Joshi, chairman of Pharmexcil, underlined the council’s crucial work in promoting Indian pharmaceutical exports, supporting exporters, and advancing bilateral market access between India and Brazil.
Discussions are also aimed at regulatory affairs and challenges between Brazil and India. This will also address the impact of new Brazilian regulations and highlight the institutional support Brazil can provide to both Indian and Brazilian companies.
In Exports, NAFTA, Europe, and Africa are the three major regions for pharma exports, together accounting for approximately 70.46% of total exports in April 2025.
NAFTA comprised 39.46% of total exports during April 2025, valued at USD 981.02 million, reflecting a decline of -5.68% compared to April 2024.
Europe (5.06%), LAC (5.95%), ASEAN (0.46%), WANA (15.64%), CIS (10.08%) all registered positively growth during April 2025 compared to April 2024.
Africa (4.47%), NEA (-8.93%), OCEANIA (25.26%) exhibited mixed trends, with NEA region experiencing a contraction of -8.93%, followed by Africa with 4.47% growth, and Oceania showing the highest growth of 25.26%.
India’s total imports in 2024-25 amounted to USD 8,188.26 million, with April 2025 imports at USD 748.56 million. NEA held the largest share at 42.12% with USD 3,772.84 million, followed by Europe at 38.19% with USD 2,774.68 million.
NAFTA contributed 11.89% at USD 908.04 million, while ASEAN accounted for 5.20% at USD 479.71 million. LAC had a 1.05% share with USD 91.34 million, and WANA represented 0.44% at USD 53.54 million.
Oceania held 0.35% with USD 40.76 million, South Asia 0.33% at USD 44.05 million, and Africa 0.25% at USD 12.59 million. UN contributed 0.11% at USD 6.39 million, while CIS had the smallest share at 0.08% with USD 4.31 million.
|
|
|
|
|
|
|
|
TOPICS
|
Shanghai-based Hualian Pharmaceutical Machinery Company Limited, a family-run enterprise with roots going back to 1986, ...
|
|
|
|
|